Nanobiotix S.A.
NBTX
$51.50
-$3.57-6.48%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 56.14% | 57.29% | 74.05% | 76.14% | -294.83% |
| Total Depreciation and Amortization | -8.92% | -11.32% | 7.04% | -1.57% | 6.31% |
| Total Amortization of Deferred Charges | -42.86% | -45.45% | -- | -- | 290.91% |
| Total Other Non-Cash Items | -74.47% | -75.14% | -609.06% | -567.98% | 158.04% |
| Change in Net Operating Assets | -371.87% | -364.74% | -85.67% | -86.82% | -52.49% |
| Cash from Operations | -27.49% | -24.15% | -214.58% | -189.21% | -382.97% |
| Capital Expenditure | -18.65% | -15.60% | 67.67% | 70.27% | -6,948.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 68.77% | 69.57% | -15.25% | -5.00% | -467.39% |
| Cash from Investing | 0.16% | 2.76% | 65.85% | 68.61% | -1,955.08% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -6.69% | -6.69% | -21.90% | -21.90% | -12.06% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -431.54% | -431.54% | 44.83% | 44.83% | 96.04% |
| Cash from Financing | 1,872.21% | 1,825.80% | -12.40% | -3.33% | -105.02% |
| Foreign Exchange rate Adjustments | 141.91% | 136.07% | -1,364.94% | -1,263.09% | 252.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 257.46% | 253.33% | -146.51% | -126.63% | -130.63% |